Table 2 Treatment characteristics
Number of patients and spinal metastases | 32 and 54 |
Median GTVcc (range) | 3.3 (0.2–53.8) |
Median CTVcc (range) | 20.3 (5.0–136.1) |
Median PTVcc (range) | 26.5 (7.6–250.6) |
Spinal treatment (%) | |
SBRT (single dose) | 4 (7.5%) |
12 Gy in 1 fractions | 4 (100%) |
SBRT (multiple doses) | 49 (92.5%) |
4 Gy in 3 fractions | 2 (4.1%) |
6 Gy in 3 fractions | 13 (26.5%) |
7 Gy in 3 fractions | 20 (40.8%) |
8 Gy in 3 fractions | 14 (28.6%) |
Dose prescription | |
Median (Gy; range) | 21 Gy (12–24 Gy) |